icon Earnings Announcement Before Market Open

Eli Lilly and Co LLY:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 5:38 PM EDT

776.20

-4.90 (-0.63%)

Volume

321,542

781.10

+43.90 (+5.95%)

Volume

6,693,253

52 week range

392.26 - 800.78

Open775.00
Day High795.50
Day Low767.66
Prev Close737.20
52 Week High800.78
52 Week High Date03/04/24
52 Week Low392.26
52 Week Low Date05/01/23

Key Stats

Market Cap742.643B
Shares Out950.77M
10 Day Average Volume2.47M
Dividend5.20
Dividend Yield0.67%
Beta0.38
YTD % Change34

KEY STATS

Open775.00
Day High795.50
Day Low767.66
Prev Close737.20
52 Week High800.78
52 Week High Date03/04/24
52 Week Low392.26
52 Week Low Date05/01/23
Market Cap742.643B
Shares Out950.77M
10 Day Average Volume2.47M
Dividend5.20
Dividend Yield0.67%
Beta0.38
YTD % Change34

RATIOS/PROFITABILITY

EPS (TTM)5.80
P/E (TTM)134.65
Fwd P/E (NTM)62.40
EBITDA (TTM)11.853B
ROE (TTM)48.93%
Revenue (TTM)34.124B
Gross Margin (TTM)79.25%
Net Margin (TTM)15.36%
Debt To Equity (MRQ)234.18%

EVENTS

Earnings Date04/30/2024
Ex Div Date11/14/2023
Div Amount1.13
Split Date-
Split Factor-

Latest On Eli Lilly and Co

Jim Cramer says GEHC's unwarranted post-earnings plunge is a buying opportunity3 Hours AgoCNBC.com
Lilly assures investors it can overcome the high-quality problem of too much demand4 Hours AgoCNBC.com
Stocks making the biggest moves midday: Eli Lilly, 3M, PayPal, Tesla and more5 Hours AgoCNBC.com
Tuesday, April 30, 2024: Jim Cramer says this industrial stock will see tailwinds from data centers7 Hours AgoCNBC.com
Eli Lilly is a 'multi-diversified drugmaker', says Cantor Fitzgerald's Louise Chen8 Hours AgoCNBC.com

Content From Our Affiliates

LLY Earnings: Eli Lilly Gains on Strong Q1 Earnings Beat8 Hours AgoTipRanks
Analysts’ Top Healthcare Picks: Qiagen (QGEN), Eli Lilly & Co (LLY)8 Hours AgoTipRanks
Bank of America Securities Keeps Their Buy Rating on Eli Lilly & Co (LLY)8 Hours AgoTipRanks
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum11 Hours AgoTipRanks
Notable companies reporting before tomorrow’s openApril 29, 2024TipRanks

Profile

Eli Lilly and Company is engaged in drug manufacturing businesses. The Company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Humulin, Jardiance, Mounjaro, Trulicity and Zepbound. Its oncology products include Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh and Taltz....

David Ricks

Chairman of the Board, President, Chief Executive Officer

Anat Ashkenazi

Chief Financial Officer, Executive Vice President

Diogo Rau

Executive Vice President, Chief Information and Digital Officer

Patrik Jonsson

Executive Vice President, President of Lilly Diabetes and Obesity and President of Lilly USA

Alonzo Weems

Executive Vice President - Enterprise Risk Management, Chief Ethics and Compliance Officer

Address

Lilly Corporate Ctr

Drop Code 1094, Lilly Corporate Ctr

Indianapolis, IN

46285-0001

United States

https://www.lilly.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
MRK Merck & Co Inc	129.22	-0.90	-0.69%
ABBV AbbVie Inc	162.64	+1.12	+0.69%
JNJ Johnson & Johnson	144.59	-2.23	-1.52%
AZN AstraZeneca PLC	75.88	+0.40	+0.53%
NVS Novartis AG	97.13	+0.04	+0.04%